Our study provided the first connection between UPRmt and osteogenesis, suggesting a possible mechanism underlying the pathology of m.3243A > G related osteoporosis, and identified ATF5 as a potential therapeutic target for this disease. This evidence concerns the gene ATF5 and osteoporosis.